Similarly, we reasoned that by avoiding the tissue damage and inflammatory cytokine production associated with MAC and further suppressing JAK/STAT dependant cytokine production, in particular IL6, the rates of GVHD onset may be reduced in alloSCT recipients (24, 25). The gene discussed is SOAT1; the disease is graft versus host disease.